Risperidone ( DrugBank: Risperidone )


5 diseases
IDDisease name (Link within this page)Number of trials
8Huntington disease2
156Rett syndrome1
179Williams syndrome1
187Kabuki syndrome1
206Fragile X syndrome1

8. Huntington disease


Clinical trials : 242Drugs : 205 - (DrugBank : 62) / Drug target genes : 85 - Drug target pathways : 159 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

156. Rett syndrome


Clinical trials : 44Drugs : 61 - (DrugBank : 23) / Drug target genes : 57 - Drug target pathways : 83 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

179. Williams syndrome


Clinical trials : 5Drugs : 14 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 32 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

187. Kabuki syndrome


Clinical trials : 4Drugs : 9 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 11 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

206. Fragile X syndrome


Clinical trials : 108Drugs : 91 - (DrugBank : 36) / Drug target genes : 52 - Drug target pathways : 77 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries